Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
featured
Published in Cardiology

Journal Scan / Research · November 03, 2022

P2Y12 Inhibitor vs Aspirin Monotherapy Following DAPT After PCI

JACC: Cardiovascular Interventions

 

Additional Info

Disclosure statements are available on the authors' profiles:

JACC: Cardiovascular Interventions
P2Y12 Inhibitor or Aspirin Following Dual Antiplatelet Therapy After Percutaneous Coronary Intervention: A Network Meta-Analysis
JACC Cardiovasc Interv 2022 Oct 26;[EPub Ahead of Print], G Andò, GA De Santis, A Greco, et al

Further Reading